Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.

Looking to the future:
Working together to improve
diabetes care

Book your place for our upcoming virtual conference

16 September 2021

Next event starting shortly. Already registered?

The Primary Care Diabetes Society (PCDS)

11th annual Northern Ireland Conference

This year, the Northern Irish Conference of the PCDS is celebrating its 11th anniversary and will be doing so in a virtual format. Building on our heritage we will explore ‘looking to the future’ for clinical diabetes care in Northern Ireland. Among the topics that we will cover are catching up with COVID-19, obesity and diabetes, risk stratification and resetting services, and the latest on foot care fundamentals.

As always, you will be able to pick up best-practice tips and hear from the experts on a whole range of clinical issues that are central to high-quality diabetes care.

We very much hope to see you there virtually.

Northern Ireland Representatives on the PCDS Committee

This fast-paced, interactive conference combines latest clinical guidance, research, case studies and hot topics in diabetes, including lessons learned from COVID-19 and much more

  • Ask the experts your burning questions through the LIVE Q&A at the end of each session
  • Log on anytime during the day from the comfort of your own home to view the sessions ​
  • Don’t worry if you miss something, all of the content will be available on-demand
  • Claim 5 CPD points for the full day virtual conference

Agenda

09:00

Chair’s introduction

09:10

Catching up with COVID 19 and Diabetes

  • New evidence about COVID in diabetes
  • New treatments and vaccination
  • Lessons learned about COVID in people with diabetes

15 min break

09:55

DAPA-CKD trial overview

AstraZeneca promotional symposium.

15 min break

10:40

Understanding and managing cardiorenal metabolic disease

  • Cardiovascular and renal disease, the relationship with diabetes
  • Additional factors, hypertension, dyslipidemia and insulin resistance
  • New medications and guidance

15 min break

11:25

‘In Practice’ masterclasses | Rotation 1

1. Risk stratification and resetting services: Improving care and providing support for people with diabetes

  • Identifying priorities (frailty, reviews, pre-diabetes)
  • Encompassing lessons learned during the pandemic (remote consultation and self-management)
  • Making an achievable plan to provide an improved service

2. Injectable medication in the management of diabetes: Initiating, supporting and getting it right

  • Initiating injectable medication (face-to-face and remotely)
  • Injection education resources
  • Supporting the patient by remote consultation
  • Providing continuity of care by follow-up and review

3. Foot care fundamentals in diabetes: Diagnosis, management and the importance of review

  • Emphasising the importance of review
  • What to look for? Test and diagnosis
  • Providing patient support
  • Practical footcare, telling the patient what to do

4. Type 2 diabetes – Supporting more effective clinical management in routine care

  • Making sense of reports to improve clinical outcomes
  • Helping patients to help themselves
  • Enabling discussion to improve Time in range

 

Session organised and supported by Abbott Laboratories Ltd.

15 min break

12:20

‘In Practice’ masterclasses | Rotation 2

1. Risk stratification and resetting services: Improving care and providing support for people with diabetes

  • Identifying priorities (frailty, reviews, pre-diabetes)
  • Encompassing lessons learned during the pandemic (remote consultation and self-management)
  • Making an achievable plan to provide an improved service

2. Injectable medication in the management of diabetes: Initiating, supporting and getting it right

  • Initiating injectable medication (face-to-face and remotely)
  • Injection education resources
  • Supporting the patient by remote consultation
  • Providing continuity of care by follow-up and review

3. Foot care fundamentals in diabetes: Diagnosis, management and the importance of review

  • Emphasising the importance of review
  • What to look for? Test and diagnosis
  • Providing patient support
  • Practical footcare, telling the patient what to do

15 min break

13:15

Obesity and diabetes: Improving health and DIRECTing diabetes remission

  • Examining the issues around diabetes and obesity including COVID 19, GLP-1s and possible remission
  • Providing an update on the DIRECT trial
  • Does bariatric surgery have a role to play

15 min break

14:00

An evidence-informed yet person-centred approach to the management of cardiovascular risk in type 2 diabetes

This is a promotional symposia slot sponsored by Lilly.

Please note this session is not eligible for accreditation.

Relevant prescribing information and adverse event reporting can be found on the platform

PP-LD-GB-1277 August 2021

15 min break

14:45

Diabetes Distilled: Providing an update on diabetes in primary care

  • Latest evidence and developments
  • Diabetes in a post-COVID world
  • New medication and technology
  • Current guidelines and how they apply to primary care

15:15

Chair’s concluding remarks

Speakers

Ameet-Bakhai-300.jpg

Ameet Bakhai

Consultant Cardiologist and Cardiovascular R&D Director, Royal Free London NHS Trust

Heather-Bell.png

Heather Bell

GP, Greenisland

Nigel-Campbell.png

Nigel Campbell

GP, Lisburn

Brian-Conner-200

Brian Connor

Chair and GP Lead, Causeway ICP

Su_Down.png

Su Down

Diabetes Nurse Consultant, Somerset

Dr-Kevin-Fernando.jpg

Kevin Fernando

GPwSI in Diabetes and Medical Education, North Berwick

Fraser-Gibb

Fraser Gibb

Consultant Endocrinologist and Honorary Senior Lecturer

Lesley-Hamilton.png

Lesley Hamilton

Diabetes Network Manager, Western Trust

Roy_Harper.png

Roy Harper

Consultant Physician and Visiting Professor, Belfast

Kamlesh-Khunti.png

Kamlesh Khunti

Professor of Primary Care Diabetes and Vascular Medicine, Leicester

Paul-McMullen.jpg

Paul McMullen

Consultant Endocrinology and Diabetes

Ciara-Mulligan-300.jpg

Ciara Mulligan

Consultant Physician in Diabetes and Endocrinology, Ulster Hospital, Dundonald

Waqas-Tahir-300.jpeg

Waqas Tahir

GPwER in Diabetes, GP Partner, Affinity Care Clayton, and Diabetes Lead, Bradford Care Alliance

Helen-Wallace-200

Helen Wallace

Consultant Physician in Endocrinology & Diabetes, Royal Victoria Hospital, Belfast

Prof David Wheeler

David Wheeler

Professor of Kidney Medicine, University College London, and Honorary Consultant Nephrologist, Royal Free London NHS Foundation Trust

Conference sponsors

GOLD SPONSOR

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

AstraZeneca operates in five different locations in the UK, where around 8,300 employees work in research and development, manufacturing, supply, sales and marketing. We supply 40 different medicines to the NHS. The UK is also an important location for AstraZeneca’s clinical trials; in 2018, there were 201 trials at 376 centres in the UK, involving over 7,000 patients. For more information, please visit www.astrazeneca.co.uk

SILVER SPONSOR

Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission.

To learn more, visit www.lilly.co.uk

MASTERCLASS SPONSOR

Abbott’s diabetes care division

At Abbott, we believe people with diabetes should have the freedom to enjoy a full, active life. That’s why we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor their glucose and providing healthcare teams with more data to drive better informed treatment decisions.

BRONZE SPONSOR

AgaMatrix Europe Ltd.

The WaveSense JAZZtest strip has been a popular choice for CCGs, Health Boards and HCPs for many years, resulting in it being the 2nd most prescribed test strip in the UK.  AgaMatrix have worked hard to secure this position by offering high quality, accurate blood glucose testing combined with second-to-none support.

The WaveSense JAZZtest strip is used in all three WaveSense JAZZ blood glucose monitoring systems including the increasingly popular WaveSense JAZZWIRELESS blood glucose meter which enables remote management of patients.

Find out more about more about how AgaMatrix can support your practice with the implementation of AgaMatrix Clinic Review Service.  This free of charge service assists GP practices to optimise blood glucose prescribing and is fully managed from beginning to end by the AgaMatrix pharmacy team under the control of the GP surgery throughout the process.  A remote version of the service is now available.

Novo Nordisk

At Novo Nordisk, our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. Novo Nordisk is a leading global healthcare company, founded in 1923 and our heritage has given us experience and capabilities that enable us to expand access to our medicines and work to prevent and ultimately cure disease by pioneering scientific breakthroughs. Headquartered in Denmark, Novo Nordisk employs approximately 45,000 people in 80 countries and markets its products in around 170 countries. Every day, millions of people all over the world rely on our products. For more information visit www.novonordisk.co.uk

Taking place on:

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.